Jagsonpal Pharmaceuticals Q4 Results

  • BSE: 507789
  • NSE: JAGSNPHARM
  • ISIN: INE048B01027
  • Sector: Major Drugs
BSE
675.635.40 (5.53%)
Volume43.72 K
Updated: Mon 25 Nov, 2024 | 15:41:47
NSE
67133.30 (5.22%)
Volume3.97 L
Updated: Mon 25 Nov, 2024 | 15:42:00
Today: 643.30
686.80
52-Wk: 270.05
654.95

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jagsonpal Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 43.4960.14-%55.45-%
    Selling/ General/ Admin Expenses Total 11.4514.19-%13.21-%
    Depreciation/ Amortization 0.400.33-%0.48-%
    Other Operating Expenses Total 9.4310.49-%9.47-%
    Total Operating Expense 41.2251.84-%50.75-%
    Operating Income 2.278.30-%4.70-%
    Net Income Before Taxes 4.549.87-%7.32-%
    Net Income 3.557.78-%5.60-%
    Diluted Normalized EPS 1.312.97-%2.22-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts